| Ryan Reynolds helps Fox foundation |
Variety |
Jul 28 2010 |
| NIH and the Drug Discovery Pipeline - ASPET responds to Newsweek |
ASPET PharmTalk |
Jun 1 2010 |
| Can academia bridge the gap between bench and bedside? |
Xconomy |
May 12 2010 |
| Lindsley lands award for translational pharmacology |
VUMC Reporter |
Apr 15 2010 |
| Novel grant supports drug discovery effort |
VUMC Reporter |
Mar 19 2010 |
| Hot New Papers |
ScienceWatch.com |
Mar 2010 |
Cracking The Tough Ones
Drug firms hope to accelerate their quest for evasive cures through partnerships |
Chemical & Engineering News |
Feb 22 2010 |
| Fragile hope for brain disorders |
Drug Discovery News |
Feb 2010 |
| Developmental disorders drug research bolstered |
VUMC Reporter |
Jan 8 2010 |
| VU's Conn advocates new models for drug discovery |
Venture Nashville Connections |
Dec 22 2009 |
| Allosteric drugs promise precise control over diseases mediated by G-protein-coupled receptors |
Chemical & Engineering News |
Nov 23 2009 |
| Parkinson’s disease research highlighted |
The Reporter |
Oct 23 2009 |
| Michael J. Fox Foundation Strategy for Accelerating Parkinson's Research - VIDEO |
Michael J. Fox Foundation Video |
Nov 21 2009 |
| Leaders in the Study of Allosteric Modulation to Discuss Latest Research at Allosteric and Orthosteric Modulator Congress |
Pharmacology Blogs |
Nov 4 2009 |
| Discovery of mGluR4 Potentiators for Symptomatic and Disease-Modifying Treatment of PD - VIDEO of Jeff Conn's recent presentation at the 2009 PD Therapeutics Conference |
PD Online Research |
Sep 30 2009 |
| Michael J. Fox Foundation-Funded Team Pursuing Glutamate-based Treatment for Parkinson's Disease Hits Major Milestone |
Michael J. Fox Foundation News Release |
Sep 30 2009 |
| Michael J. Fox Foundation Q&A with Jeff Conn on His Team's Milestone in Pursuit of a Glutamate-Based Therapy for Parkinson's Disease |
Michael J. Fox Foundation News Release |
Sep 30 2009 |
| Jeff Conn, Ph.D., on Fragile X drug discovery |
VUMC Podcast |
Aug 2009 |
| A New Kind of Drug Target |
Scientific American |
Aug 2009 |
| Targeting M1—The Agony of Agonists, the Power of Potentiators |
Alzheimer Research Forum |
Aug 28, 2009 |
| Adventures in glutamate: The difficult and expensive path of novelty in drug discovery |
In Vivo: The Business & Medicine Report |
Jul/Aug 2009 |
| Vanderbilt Program in Drug Discovery - Fragile X podcast |
VUMC Podcast |
Jul 22, 2009 |
| Breaking the Mold (Alternate PDF Version link) |
Chemical & Engineering News |
Apr 20, 2009 |
| Moving from Theory to Therapy |
Nashville Medical News |
Feb 2009 |
| Town meets gown in J&J-Vandy deal |
Drug Discovery News |
Feb 2009 |
Vandy-J&J partnership could change the way new drugs are produced
(Alternate audio file link) |
WKYU Radio (NPR Affiliate
Station) |
Feb 16 , 2009 |
| Vanderbilt Forms Pact With J&J |
Chemical & Engineering News |
Jan 19, 2009 |
| VU, Janssen team in drug discovery effort |
The Reporter |
Jan 16, 2009 |
| Janssen-Vanderbilt; Baxter-Northwestern R&D Pacts Support Idea of Academic Labs as CROs |
Biotech Transfer Week |
Jan 14, 2009 |
J&J, Vanderbilt Team Up on Schizophrenia Drugs
(Alternate PDF Version link) |
Wall Street Journal |
Jan 9, 2009 |
| J&J-Vanderbilt in unusual schizophrenia drug deal |
Forbes.com |
Jan 9, 2009 |
| GPCR Market Exhibits Rapid Diversification |
Genetic Engineering & Biotechnology News |
Oct 15, 2008 |
| Fine-Tuning the Design of GPCR Therapeutics |
Genetic Engineering & Biotechnology News |
Oct 15, 2008 |
| TBPB or Not to Be—The Latest on Muscarinic Receptor Agonists |
Alzheimer Research Forum |
Oct 8 , 2008 |
| Vanderbilt joins high-tech drug discovery effort |
The Reporter |
Sept 12, 2008 |
| A Mind Disabled |
Vanderbilt Medicine |
Summer 2008 |
| Grant Bolsters "Fragile X" Research |
Vanderbilt Medicine |
Summer 2008 |
| Conn Contributes to Advances in GPCR Webinar .. |
Science |
June 17, 2008 |
| GPCRs Remain “Hot” Drug Targets . |
Genetic Engineering &
Biotechnology News |
May 1, 2008 |
| Daring to Think Differently About
Schizophrenia |
The New York Times |
Feb 24, 2008 |
| Conn to hold newly endowed chair honoring Limbird |
The Reporter |
Feb 22, 2008 |
| Grant bolsters ‘fragile X’ research |
The Reporter |
Feb 8, 2008 |
| Study seeks Alzheimer’s disease 'dimmer switch' |
The Reporter |
Jan 18, 2008 |
| A Different Approach to Parkinson's |
The Journal of Life Sciences |
Dec 21, 2007 |
| Grant helps spur pursuit of new Parkinson’s drugs |
The Reporter |
Dec 21, 2007 |
Acetylcholine Boost With a Twist—Compound
Targets M4 Receptors |
Alzheimer Research Forum |
Dec 6, 2007 |
| Schizophrenia Treatment Without Side Effects? |
Science |
Sept 4, 2007 |
| Schizophrenia Drug Shows Promise in Trials |
The New York Times |
Sept 3, 2007 |
| Drug discovery efforts land Conn two awards |
The Reporter |
Feb 16, 2007 |
| Clinic is key to speed new drug discovery: Conn |
The Reporter |
Feb 2, 2007 |
| Conn discusses opportunities and challenges... |
Discovery Lecture Series |
Jan 25, 2007 |
| Preclinical Drug Discovery Research and Training at Vanderbilt |
ACS Chemical Biology |
Jan 19, 2007 |
| Industry influx helps boost drug discovery... |
The Reporter |
Jan 19, 2007 |
| Meltzer to chair international mental illness meet |
The Reporter |
June 16, 2006 |
| Conn to edit pharmacology journal |
The Reporter |
Oct 14, 2005 |
| Research into Parkinson's disease enhanced... |
The Reporter |
Aug 19, 2005 |
| Network to boost discovery efforts |
The Reporter |
June 17, 2005 |
| Where are the new drugs? |
Lens Magazine |
2005 |
| Drug discovery in the 21st century |
Lens Magazine |
2005 |
| Agreement enhances drug discovery efforts |
The Reporter |
Mar 25, 2005 |
